Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Equity Ratio (2016 - 2025)

Fortress Biotech has reported Equity Ratio over the past 13 years, most recently at 0.27 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.27 for Q4 2025, up 2457.99% from a year ago — trailing twelve months through Dec 2025 was 0.27 (up 2457.99% YoY), and the annual figure for FY2025 was 0.27, up 2457.99%.
  • Equity Ratio for Q4 2025 was 0.27 at Fortress Biotech, down from 0.36 in the prior quarter.
  • Over the last five years, Equity Ratio for FBIO hit a ceiling of 0.62 in Q1 2021 and a floor of 0.1 in Q3 2024.
  • Median Equity Ratio over the past 5 years was 0.21 (2025), compared with a mean of 0.22.
  • Biggest five-year swings in Equity Ratio: crashed 220.33% in 2024 and later skyrocketed 2457.99% in 2025.
  • Fortress Biotech's Equity Ratio stood at 0.57 in 2021, then tumbled by 70.16% to 0.17 in 2022, then crashed by 94.43% to 0.01 in 2023, then plummeted by 220.33% to 0.01 in 2024, then skyrocketed by 2457.99% to 0.27 in 2025.
  • The last three reported values for Equity Ratio were 0.27 (Q4 2025), 0.36 (Q3 2025), and 0.23 (Q2 2025) per Business Quant data.